Oxsoralen Alternatives Compared
| Oxsoralen (methoxsalen) | Opzelura (ruxolitinib) | Ruxolitinib topical |
|
|---|
| Oxsoralen (methoxsalen) | Opzelura (ruxolitinib) | Ruxolitinib topical |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Vitiligo. Oxsoralen may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Vitiligo, Atopic Dermatitis. Opzelura may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Vitiligo, Atopic Dermatitis. Ruxolitinib topical may also be used for purposes not listed in this medication guide. |
||||||||
| More about Oxsoralen (methoxsalen) | More about Opzelura (ruxolitinib) | More about Ruxolitinib topical | ||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
Opzelura has an average rating of 9.5 out of 10 from a total of 4 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Ruxolitinib topical has an average rating of 9.5 out of 10 from a total of 4 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Drug Class | ||||||||||
| Side Effects | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Opzelura prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms Available | ||||||||||
|
N/A |
|
N/A |
||||||||
| Brand Names | ||||||||||
|
N/A |
N/A |
Opzelura | ||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
|
N/A |
116 hours |
116 hours |
||||||||
| CSA Schedule ** View glossary of terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. |
Summary unavailable. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 6 drugs are known to interact with Oxsoralen:
|
A total of 30 drugs are known to interact with Opzelura:
|
A total of 30 drugs are known to interact with Ruxolitinib topical:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
| First Approval Date | ||||||||||
|
N/A |
September 21, 2021 |
September 21, 2021 |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient resources | ||||||||||
| Professional Resources | ||||||||||
|
N/A |
||||||||||
| Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.